Rho J M, Donevan S D, Rogawski M A
Neuronal Excitability Section, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD 20892.
Ann Neurol. 1994 Feb;35(2):229-34. doi: 10.1002/ana.410350216.
Felbamate is a promising new antiepileptic drug whose mechanism of action is unknown. In whole-cell voltage clamp recordings from cultured rat hippocampal neurons, clinically relevant concentrations of felbamate (0.1-3 mM) inhibited N-methyl-D-aspartate (NMDA) responses and potentiated gamma-aminobutyric acid (GABA) responses. Single-channel recordings indicated that the effect on NMDA responses occurred via a channel blocking mechanism. Felbamate is the first anticonvulsant drug with dual actions on excitatory (NMDA) and inhibitory (GABA) brain mechanisms. This unique combination of effects could account for felbamate's broad spectrum of anticonvulsant activity in animal seizure models and its distinctive clinical efficacy and safety profile.
非氨酯是一种很有前景的新型抗癫痫药物,其作用机制尚不清楚。在培养的大鼠海马神经元的全细胞膜片钳记录中,临床相关浓度的非氨酯(0.1 - 3 mM)抑制N - 甲基 - D - 天冬氨酸(NMDA)反应,并增强γ-氨基丁酸(GABA)反应。单通道记录表明,对NMDA反应的影响是通过通道阻断机制发生的。非氨酯是第一种对兴奋性(NMDA)和抑制性(GABA)脑机制具有双重作用的抗惊厥药物。这种独特的效应组合可以解释非氨酯在动物癫痫模型中的广谱抗惊厥活性及其独特的临床疗效和安全性。